Also listed on Liposonix, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Collateral for a security interest recorded Jun 13, 2025 (JPMorgan Chase Bank, N.A.).
Term ends Dec 19, 2027 · Medium confidence
20-year base term ended Dec 29, 2024
Why Medium: A parent in the chain could not be resolved.
Held by Solta Medical, Inc.
Filed Apr 27, 2006 as application 11/414,080 · Granted Dec 28, 2010
Base term plus 1085 days of patent term adjustment (USPTO delay)
Today
2004
2027
Clock starts
Dec 29, 2004
Dec 29, 2004
Term ends
Dec 19, 2027
Dec 19, 2027
Granted
Dec 28, 2010
Dec 28, 2010
base term
patent term adjustment
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
1,085
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
8
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 1085 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: Medium. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 29, 2004, when the earliest non-provisional application in its chain was filed (this one was filed Apr 27, 2006); a parent in its chain could not be resolved (the next row) | Dec 29, 2024 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | +1085 days, USPTO patent term adjustment record | Dec 19, 2027 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Dec 19, 2027 | Medium confidence |
This family
| Application 10/751,344 | Abandoned not computed | not computed |
| Application 10/750,370 | Abandoned not computed | not computed |
| US 7,993,289 | Lapsed on the fee record Aug 2019 | Aug 2019 |
| US 8,337,407 | Lapsed on the fee record Dec 2016 | Dec 2016 |
| US 7,857,773 | this patent Dec 2027 | Dec 2027 |
| US 8,343,051 | Term ended Jul 2025 | Jul 2025 |
| Application 12/954,506 | Abandoned not computed | not computed |
| US 9,180,314 | Term ended Jul 2025 | Jul 2025 |
The applications whose file history this site holds. The family may have others.
Assignments
The 40 most recent of 62 recorded documents are shown; the 22 earliest are not. Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Salix Pharmaceuticals, Ltd. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Santarus, Inc. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Medicis Pharmaceutical Corporation | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Humax Pharmaceutical S.A. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Solta Medical Ireland Limited | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Bausch & Lomb Mexico, S.A. de C.V. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Bausch+lomb Ops B.V. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Bausch Health Americas, Inc. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Bausch Health Companies Inc. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Bausch Health Holdco Limited | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Bausch Health Magyarorszag KFT (A/K/A Bausch Health Hungary LLC) | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Bausch Health Poland Spolka Z Ograniczona Odpowiedzialnoscia (F/K/A Valeant Pharma Poland Spolka Z Ograniczona Odpowiedzialnoscia) | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Bausch Health US, LLC | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Bausch Health, Canada Inc. / Sante Bausch, Canada Inc. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | ICN Polfa Rzeszow Spolka Akcyjna (A/K/A ICN Polfa Rzeszow S.A.) | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Orapharma, Inc. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Przedsiebiorstwo Farmaceutyczne Jelfa Spolka Akcyjna (A/K/A Przedsiebiorstwo Farmaceutyczne Jelfa S.A.) | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Solta Medical Dutch Holdings B.V. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | V-Bac Holding Corp. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | VRX Holdco LLC | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | 1261229 B.C. Ltd. | Release of Security Interest |
| Apr 8, 2025 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | 1530065 B.C. Ltd. | Release of Security Interest |
| Jun 13, 2025 Reel 71564, frame 463 | Medicis Pharmaceutical Corporation; Orapharma, Inc.; Bausch Health US, LLC (F/K/A Valeant Pharmaceuticals North America LLC); Precision Dermatology, Inc.; Salix Pharmaceuticals, Inc.; Santarus, Inc.; Bausch Health Americas, Inc.; Solta Medical, Inc. | The Bank of New York Mellon | U.S. Patent Security Agreement |
| Jun 13, 2025 Reel 71566, frame 200 | Medicis Pharmaceutical Corporation; Orapharma, Inc.; Bausch Health US, LLC (F/K/A Valeant Pharmaceuticals North America LLC); Precision Dermatology, Inc.; Salix Pharmaceuticals, Inc.; Santarus, Inc.; Bausch Health Americas, Inc.; Solta Medical, Inc. | Jpmorgan Chase Bank, N.a. | U.S. Patent Security Agreement |
| Nov 20, 2025 Reel 73637, frame 126 | The Bank of New York Mellon, as Notes Collateral Agent | Bausch Health Americas, Inc.; Bausch & Lomb Incorporated; Bausch Health US, LLC; Solta Medical, Inc.; Medicis Pharmaceutical Corporation; Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Orapharma, Inc.; Precision Dermatology, Inc. | Release of Security Interest |
| Nov 20, 2025 Reel 73654, frame 300 | The Bank of New York Mellon, as Notes Collateral Agent | Bausch Health Companies Inc.; Bausch Health, Canada Inc.; Bausch Health Ireland Limited; Solta Medical Ireland Limited | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Bausch Health Americas, Inc. | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Bausch & Lomb Incorporated | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Bausch Health US, LLC | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Solta Medical, Inc. | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Medicis Pharmaceutical Corporation | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Salix Pharmaceuticals, Inc. | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Salix Pharmaceuticals, Ltd. | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Santarus, Inc. | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Orapharma, Inc. | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Precision Dermatology, Inc. | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Bausch Health Companies Inc. | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Bausch Health, Canada Inc. | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Bausch Health Ireland Limited | Release of Security Interest |
| Nov 20, 2025 reel/frame not recorded | The Bank of New York Mellon, as Notes Collateral Agent | Solta Medical Ireland Limited | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Dec 2027
Term ends Dec 19, 2027. No further fees fall due before then
Note
The 1085 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
376
later US patents cite this one
That is top 1% of utility patents granted in 2010 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.